Yueping Liu
- Infectious Diseases top 0.5%
- Neurology top 1%
- Molecular Biology
- Immunology top 10%
- Oncology top 10%
- Topics
- SARS-CoV-2 and COVID-19 Research (8 papers)Plant Molecular Biology Research (8 papers)COVID-19 Clinical Research Studies (6 papers)
In The Last Decade
Yueping Liu
27 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Infectious Diseases 1.8k
- Neurology 918
- Molecular Biology 488
- Immunology 344
- Oncology 274
Countries citing papers authored by Yueping Liu
This map shows the geographic impact of Yueping Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueping Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueping Liu more than expected).
Fields of papers citing papers by Yueping Liu
This network shows the impact of papers produced by Yueping Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueping Liu. The network helps show where Yueping Liu may publish in the future.
Co-authorship network of co-authors of Yueping Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Yueping Liu. A scholar is included among the top collaborators of Yueping Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yueping Liu. Yueping Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 3 | |
| 6 | 15 | |
| 7 | 10 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 3 | |
| 11 | Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infectionbreakdown → | 347 |
| 12 | 9 | |
| 13 | 33 | |
| 14 | 15 | |
| 15 | Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)breakdown → | 1724 |
| 16 | Molecular regulation mechanism of leaf development mediated by ath-miR169d in Arabidopsis thaliana. | 1 |
| 17 | 38 | |
| 18 | 10 | |
| 19 | 39 | |
| 20 | Effect of RhoA signaling transduction on expression of Ezrin in breast cancer cell lines. | 8 |
About Yueping Liu
Yueping Liu is a scholar working on Infectious Diseases, Immunology and Plant Science, having authored 31 papers that have together received 2.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), Plant Molecular Biology Research (8 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Neurology (918 citations) and Biological Psychiatry (48 citations). Yueping Liu has collaborated with scholars based in China and Estonia. Frequent co-authors include Bo Diao, Zilin Yuan, Yongwen Chen, Zeqing Feng, Yingjun Tan, Chenhui Wang, Yuzhang Wu, Li Chen, Min Li and Ying Liu. Their work appears in journals such as Nature Communications, PLANT PHYSIOLOGY and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.